Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Classement en actions #24646
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Prix de l'action
$3.06
Capitalisation boursière
$58.25M
Changement (1 jour)
-0.65%
Changement (1 an)
-73.27%
Pays
US
Échange Elicio Therapeutics, Inc. (ELTX)

Catégorie

Historique du prix de l'action pour Elicio Therapeutics, Inc. (ELTX)
Prix de clôture le plus élevé : $3.10 le 2026-08-01

Prix de clôture le plus bas : $5.88 le 2023-11-01
Historique du prix de l'action de Elicio Therapeutics, Inc. de 2023 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$547.38 37.72%
US
$1.05K 58.85%
NL
$118.70 -18.24%
AU
$140.47 435.74%
US
$770.19 9.84%
CH